• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
DMXAA

DMXAA

Product ID D509921
Cas No. 117570-53-3
Purity ≥99%
Product Unit SizeCostQuantityStock
5 mg $126.00 In stock
25 mg $288.80 In stock
100 mg $787.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

DMXAA (vadimezan) is a STING (stimulator of interferon genes) agonist. DMXAA triggers the disruption of tumor vasculature, followed by hypoxia and cell death and the release of chemokines. These events lead to tumor regression. While STING agonist activity has accounted for antitumor activity in mice, DMXAA does not bind to human STING. In addition to its antitumor activities. DMXAA has also exhibited antiviral activity.

Product Info

Cas No.

117570-53-3

Purity

≥99%

Formula

C17H14O4

Formula Wt.

282.30

Chemical Name

5,6-Dimethylxantheonone-4-acetic Acid

IUPAC Name

2-(5,6-dimethyl-9-oxoxanthen-4-yl)acetic acid

Synonym

Vadimezan; ASA-404; ASA404; 5,6-Mexaa; NSC 640488

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

D509921 MSDS PDF

Info Sheet

D509921 Info Sheet PDF

References

Weiss JM, Guérin MV, Regnier F.et al, The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression. Oncoimmunology. 2017 6(10):e1346765. doi10.1080/2162402X.2017. PMID: 29123960.

Che X, Du XX, Cai X. et.al., Single Mutations Reshape the Structural Correlation Network of the DMXAA-Human STING Complex. J Phys Chem B. 2017 121(9):2073-2082. PMID: 28178416.

Downey CM, Aghaei M, Schwendener RA. et.al., DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization. PLoS One. 2014 9(6):e99988. PMID: 24940883.

Cerón S, North BJ, Taylor SA, Leib DA. The STING agonist 5,6-dimethylxanthenone-4-acetic acid (DMXAA) stimulates an antiviral state and protects mice against herpes simplex virus-induced neurological disease. Virology. 2019 529:23-28 PMID: 30648635.

Kim S, Li L, et al. Anticancer Flavonoids Are Mouse-Selective STING Agonists. ACS Chem. Biol. 2013 8 (7):1396-1401. DOI: 10.1021/cb400264n PMID: 23683494.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • C022692

    Carbinoxamine Maleate

    Histamine H1-antagonist

    ≥98%
  • P5878

    Potassium Canrenoate

    Aldosterone antagonist.

    ≥98%
  • G7541

    GSK-1904529A

    InsR and IGF-1R inhibitor.

    ≥98%
  • I530280

    INH1

    Hec1/Nek2 mitotic pathway inhibitor

    ≥98%
  • R3477

    Ritodrine Hydrochloride

    Phenylethylamine; β2-adrenergic agonist, SK/BK...

    ≥98%
  • I5210

    INCB018424

    JAK1/2 inhibitor.

    ≥98%
  • J0001

    J-147

    Phenyl hydrazide; neuronal oxidative stress inh...

    ≥98%
  • V3455

    Vinpocetine

    Targets nuclear factor kappa B activation.

    ≥98%
  • T0140

    TAK-632

    RAF inhibitor.

    ≥99%
  • A5472

    Ansamitocin P3

    Microtubule depolymerization inhibitor.

    ≥70% (P3), Total Ansamitocins ≥95%
  • C4417

    Clemizole

    TRPC5 activator, NS4B and histamine H1 inhibito...

    ≥98%
  • A081014

    Acalabrutinib

    Inhibitor of Bruton’s tyrosine kinase (BTK).<...

    ≥99%
  • C0174

    Carmofur

    Pyrimidine analog, fluorouracil derivative; thy...

    ≥97%
  • L3374

    Lisinopril Dihydrate

    Enalapril analog; ACE inhibitor.

    ≥98%
  • A4002

    AK-7

    SIRT2 inhibitor.

    ≥98%
  • P2303

    Phallacidin

    Phallotoxin found in Amanita phalloides; microt...

    ≥98%
  • F3473

    Fisetin

    Flavonoid found in various plant sources; matri...

    ≥97%
  • A5162

    Amprolium Hydrochloride

    Thiamine, coccidiostat; thiamine transporter in...

    ≥97%
  • N1822

    Nefazodone Hydrochloride

    5-HT2 antagonist, SERT and NET inhibitor, hERG ...

    ≥98%
  • A9617

    Azelnidipine

    Dihydropyridine; L-type Ca2+ channel blocker.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only